Zena Tx partners with Rutgers and is awarded Catalyst R&D Voucher Program from CSIT
Zena partners with Rutgers University and is awarded $25,000 from the Catalyst Research and Development Voucher Pilot Program. The Zena team is excited to be collaborating with the Molecular Design and Synthesis Core under the guidance of core director, Dr. Jacques Roberge.
Zena founders attend Boehringer Ingelheim 2022 Office hours
Drs. Carry and Vasilatis present their innovations and questions to the innovative minds of Boehringer Ingelheim! An insightful experience focused on regulatory pathways and navigating the drug discovery space.
Founding Members successfully complete NSF I-Corps Winter Hub 2022
After 100 successful interviews, team Zena Therapeutics has successfully defended their beach head market and completed National I-Corps Winter Hub 2022. Special thanks to the teaching team for their insight, patience, and hard work!
Founding Members Join NSF I-Corps Winter Hub 2022
Drs. Carry, Simon, and Vasilatis have joined the National Science Foundation’s I-Corps Winter Hub 2022 as team 2457 (Zena Therapeutics)! Drs. Carry and Vasilatis take on the roles of Entrepreneurial Leads (EL) with Dr. Simon as Technical Lead (TL) and Dr. Judith Iglehart as Industry Mentor (IM). Thanks especially to Dr. Iglehart for being on our team and guiding us throughout the process!
Zena is awarded NIDA “Start an SUD Start-up Challenge”
Our very own CSO, Dr. Eileen Carry, is serving as principle investigator of this innovative mentorship provided by NIDA. The programme focuses on substance use disorder and turning ideas into innovations. We are excited to meet our mentor, Elena Koustova, and the teaching team!